Decrease of mitochondrial protein levels in human OPMD muscle biopsies. by Aymeric Chartier (713911)

NEMO knockout murine dermal fibroblasts show a decreased nuclear translocation of p65. by Patrick Meyer (3395285)

AMS scores decrease over three days at high-altitude. by Erica C. Heinrich (6832055)

Loss of nsp14-ExoN activity decreases recombination frequency and alters recombination junction patterns across the genome. by Jennifer Gribble (10005444)

Decreased reductase activity and increased round body formation in the <i>gpsA</i> mutant. by Dan Drecktrah (36180)

Boron Leaching Decreases withIncreases on Soil pH by Alessandra Aparecida de Sá (12700698)

“…The experiment was carried out in the laboratory in 2012, and treatments consisted of a factorial combination of two rates of liming (without and with lime to raise the soil pH to 6.0) and five rates of B (0, 10, 20, 50 and 100 mg kg-1, as boric acid). …”

HO-1 overexpression decreases Nox4 activity in C-20/A4 chondrocytes. by Francis Rousset (424375)

Table_1_Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study Followed Up to... by Ming-Ling Chang (44638)

“…Patients with baseline cirrhosis (2.78 ± 2.56 vs. 6.84 ± 9.00 mg/dL, p=0.024) and UDCA nonresponders (2.54 ± 2.19 vs. 4.51 ± 6.99 mg/dL, p=0.006) had increased total bilirubin levels while patients without cirrhosis (AST: 91.5 ± 84.5 vs. 58.9 ± 43.7 U/L, p<0.001; ALT: 107.3 ± 122.5 vs. 50.7 ± 36.8 U/L, p<0.001) and UDCA responders (AST: 83.8 ± 101.3 vs. 45.58 ± 38.42 U/L, p=0.014; ALT: 95.10 ± 144.6 vs. 39.12 ± 30.65 U/L, p=0.009) had decreased aminotransferase levels. …”

Image_1_Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study Followed Up to... by Ming-Ling Chang (44638)

“…Patients with baseline cirrhosis (2.78 ± 2.56 vs. 6.84 ± 9.00 mg/dL, p=0.024) and UDCA nonresponders (2.54 ± 2.19 vs. 4.51 ± 6.99 mg/dL, p=0.006) had increased total bilirubin levels while patients without cirrhosis (AST: 91.5 ± 84.5 vs. 58.9 ± 43.7 U/L, p<0.001; ALT: 107.3 ± 122.5 vs. 50.7 ± 36.8 U/L, p<0.001) and UDCA responders (AST: 83.8 ± 101.3 vs. 45.58 ± 38.42 U/L, p=0.014; ALT: 95.10 ± 144.6 vs. 39.12 ± 30.65 U/L, p=0.009) had decreased aminotransferase levels. …”

PF treatment decreases the levels of IL-1β(A) and TNFα(B) in plasma. by Ruo-Bing Guo (298949)

Decrease of GFP-TbAtg8 fluorescence during starvation. by Remo S. Schmidt (546946)

CaA decreases the CSCs-like properties of malignant HaCaT cells by p38. by Ye Yang (297214)

Treatment with anti-JAM-C antibody decreases the T-cell response by Gaby Palmer (636)

Force analysis of a single rib. by Jianbo Jia (717814)

Subjects:

Fig 5 - by Mestewat Simeon (19233200)

Treatment with rSFRP4 results in decreased Wnt signalling. by Caroline E. Ford (289563)

“…Results represent the average of 3 experiments and bars represent the standard deviation (s.d) of the mean. *<i>P</i><0.05. (<b>B</b>) Representative immunoblots showing increased SFRP4 and decreased nuclear β-catenin protein expression in OVCAR3 cells following 72 hours treatment with rSFRP4 (5 µg/ml). …”

Aβ42 increases the level of tau in the cytosol and decreases the level of microtubule-bound tau. by Kanae Ando (1951501)

DG treatment decreased the oxidative stress induced by Aβ_1–42. by Xiaolei Zhu (325492)

DC depletion decreases bacterial load upon bacterial infection. by Stella E. Autenrieth (182751)

Discrimination performance deteriorated as the safe-to-conditioned ΔF decreased. by Chi Chen (67021)